Evaluation of two-point Dixon water-fat separation for liver specific contrast-enhanced assessment of liver maximum capacity

Gadoxetic acid-enhanced magnetic resonance imaging has become a useful tool for quantitative evaluation of liver capacity. We report on the importance of intrahepatic fat on gadoxetic acid-supported T1 mapping for estimation of liver maximum capacity, assessed by the realtime 13C-methacetin breathing test (13C-MBT). For T1 relaxometry, we used a respective T1-weighted sequence with two-point Dixon water-fat separation and various flip angles. Both T1 maps of the in-phase component without fat separation (T1_in) and T1 maps merely based on the water component (T1_W) were generated, and respective reduction rates of the T1 relaxation time (rrT1) were evaluated. A steady considerable decline in rrT1 with progressive reduction of liver function could be observed for both T1_in and T1_W (p < 0.001). When patients were subdivided into 3 different categories of 13C-MBT readouts, the groups could be significantly differentiated by their rrT1_in and rrT1_W values (p < 0.005). In a simple correlation model of 13C-MBT values with T1_inpost (r = 0.556; p < 0.001), T1_Wpost (r = 0.557; p < 0.001), rrT1_in (r = 0.711; p < 0.001) and rrT1_W (r = 0.751; p < 0.001), a log-linear correlation has been shown. Liver maximum capacity measured with 13C-MBT can be determined more precisely from gadoxetic acid-supported T1 mapping when intrahepatic fat is taken into account. Here, T1_W maps are shown to be significantly superior to T1_in maps without separation of fat.

[1]  C. Stroszczynski,et al.  Volume-assisted estimation of liver function based on Gd-EOB-DTPA–enhanced MR relaxometry , 2016, European Radiology.

[2]  Markus Grube,et al.  Hepatic Uptake of the Magnetic Resonance Imaging Contrast Agent Gd-EOB-DTPA: Role of Human Organic Anion Transporters , 2010, Drug Metabolism and Disposition.

[3]  S. Qu,et al.  The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD) , 2010, Lipids in Health and Disease.

[4]  Meng-Su Zeng,et al.  Assessing liver function in patients with HBV-related HCC: a comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI , 2015, European Radiology.

[5]  J. Everhart,et al.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.

[6]  A. Teufel,et al.  Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry , 2017, Scientific Reports.

[7]  W. T. Dixon Simple proton spectroscopic imaging. , 1984, Radiology.

[8]  E. Alexopoulou,et al.  Use of fat suppression in R₂ relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. , 2012, Magnetic resonance imaging.

[9]  Christian Stroszczynski,et al.  Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI , 2013, PloS one.

[10]  T. Utsunomiya,et al.  Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve , 2012, Journal of Gastroenterology.

[11]  M. D. Nickel,et al.  Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test , 2018, European Radiology.

[12]  S. Akata,et al.  Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI. , 2013, Magnetic resonance imaging.

[13]  K. Kamimura,et al.  Quantitative evaluation of liver function with T1 relaxation time index on Gd‐EOB‐DTPA‐enhanced MRI: Comparison with signal intensity‐based indices , 2014, Journal of magnetic resonance imaging : JMRI.

[14]  S. Kumano,et al.  Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging , 2011, Investigative radiology.

[15]  M. Bock,et al.  Intravascular contrast agent T1 shortening: fast T1 relaxometry in a carotid volunteer study , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[16]  G. Glover Multipoint dixon technique for water and fat proton and susceptibility imaging , 1991, Journal of magnetic resonance imaging : JMRI.

[17]  A. Schreyer,et al.  MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score , 2014, Scientific Reports.

[18]  D. Seehofer,et al.  How to define initial poor graft function after liver transplantation? – a new functional definition by the LiMAx test , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[19]  L. Adams,et al.  International Journal of Molecular Sciences the Natural Course of Non-alcoholic Fatty Liver Disease , 2022 .

[20]  E. Jung,et al.  Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion. , 2017, Clinical hemorheology and microcirculation.

[21]  T. Miyati,et al.  The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver. , 2015, The British journal of radiology.

[22]  B. Thapa,et al.  Liver function tests and their interpretation , 2007, Indian journal of pediatrics.

[23]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[24]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[25]  Peter Kellman,et al.  Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method , 2012, Journal of Cardiovascular Magnetic Resonance.

[26]  Sanjeev Chawla,et al.  MR‐visible lipids and the tumor microenvironment , 2011, NMR in biomedicine.

[27]  P. Kellman,et al.  Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques , 2015, Journal of Cardiovascular Magnetic Resonance.

[28]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[29]  B. Taouli,et al.  3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. , 2015, Magnetic resonance imaging.

[30]  K. Kamimura,et al.  Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function , 2014, European Radiology.

[31]  D. Seehofer,et al.  The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.